Rao Raghu has filed 3 insider transactions across 1 company since December 2023.
Most recent transaction: a disposition of 22356 shares of Sonnet BioTherapeutics Holdings, Inc. ($SONN) on December 02, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Rao Raghu | Chief Executive Officer | D | Common Stock | 22356 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.32% |
| July 11, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Rao Raghu | Interim CEO | A | Common Stock | 20000 | $0.00 | 22,356.0000 | 3,332,728 | 848.90% | 0.60% |
| Dec. 11, 2023 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Rao Raghu | Director | A | Common Stock | 373 | $0.00 | 2,356.0000 | 0 | 18.81% | 0.00% |